HK Movers | Bao Pharma Jumps 105% in Grey Market
View all comments(0)
Bao Pharma shares jumped 105.3% in in Hong Kong grey market.

Founded in 2019, Bao Pharma focuses on four key therapeutic areas, including large-volume subcutaneous drug delivery systems, antibody-mediated autoimmune disease therapies, assisted reproduction and recombinant biologics.
The company recorded revenue of 41.99 million yuan ($5.94 million) in the first half of this year, up 27.2 times year-on-year from 1.49 million yuan in the same period last year. During the same period, its loss widened 9.4% year-on-year to 180 million yuan.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Qualcomm Stock Holds Rising Trendline as Amazon AI Deal Puts $182.70 Breakout in Focus

Salesforce vs. ServiceNow: SaaS Sees AI Turnaround, Which Has More Upside Potential, CRM or NOW?

US Stocks End Four-Day Losing Streak, Dow Rises 500 Points; Dell Surges 12%, Oracle Reverses Gains to Fall Nearly 2% Post-Earnings

Copper Surges to Record High: Which Copper Stocks Are Worth Watching?

SpaceX Stock Price Forecast: As Stock Lockups Intensify, Can SPCX Peak at $225 by 2027?






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.